0000950103-20-007587.txt : 20200415
0000950103-20-007587.hdr.sgml : 20200415
20200415194541
ACCESSION NUMBER: 0000950103-20-007587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200413
FILED AS OF DATE: 20200415
DATE AS OF CHANGE: 20200415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zacharias Isaac
CENTRAL INDEX KEY: 0001768265
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38829
FILM NUMBER: 20794815
MAIL ADDRESS:
STREET 1: 5403 BETSY ROSS DRIVE
CITY: SANTA CLARA
STATE: CA
ZIP: 95054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shockwave Medical, Inc.
CENTRAL INDEX KEY: 0001642545
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 270494101
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5403 BETSY ROSS DRIVE
CITY: SANTA CLARA
STATE: CA
ZIP: 95054
BUSINESS PHONE: (510) 279-4262
MAIL ADDRESS:
STREET 1: 5403 BETSY ROSS DRIVE
CITY: SANTA CLARA
STATE: CA
ZIP: 95054
FORMER COMPANY:
FORMER CONFORMED NAME: ShockWave Medical, Inc.
DATE OF NAME CHANGE: 20150515
4
1
dp126180_4-zacharias.xml
FORM 4
X0306
4
2020-04-13
0
0001642545
Shockwave Medical, Inc.
SWAV
0001768265
Zacharias Isaac
C/O SHOCKWAVE MEDICAL, INC.
5403 BETSY ROSS DRIVE
SANTA CLARA
CA
95054
0
1
0
0
Chief Commercial Officer
Common Stock
2020-04-13
4
M
0
4000
4.026
A
39000
D
Common Stock
2020-04-13
4
S
0
2490
35.0215
D
36510
D
Common Stock
2020-04-13
4
S
0
1510
35.8576
D
35000
D
Employee Stock Option (Right to Buy)
4.026
2020-04-13
4
M
0
4000
0
D
2028-04-10
Common Stock
4000
119540
D
All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 9/4/2019.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $34.47 to $35.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $35.51 to $36.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Twenty-five percent of the shares subject to the option vested on 3/1/2019 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.
/s/ Trinh Phung, as attorney in fact for Isaac Zacharias
2020-04-15